I just read of a shocking new development out of Johnson & Johnson’s research and development team. J&J claims that a topical application of their new Cytomimic Technology delivers “biological levels of electric signals similar to the skin’s natural bioelectricity.”
Hmmm. Color me dubious.
J&J’s R&D team created this Cytomimic Technology using micronized particles of copper and zinc. The claim is that as we age, our bioelectricity signaling diminishes, slowing down the cell-to-cell communication. This slows down the production of collagen and elastin. It also slows down the skin’s ability to repair and heal.
Bioelectricity is complex, and from what I know about it, it’s primarily a function of the nervous system–blinking your eye or pointing a finger are all part of this bioelectric chain. How this reduces signs of aging in the skin, when applied topically no less, is a mystery to me. J&J claims that “On the skin’s surface, the microparticles mimic the body’s electrical signal restore youthful looking skin.” Except that if you are talking about the surface of the skin, those cells are already dead, so there is no bioelectric chain to tap in to. Unless this penetrates into the dermis (the live layer).
They claim that in-vitro testing has shown anti-inflammatory activity, which is great for the skin. Except that copper and zinc are both anti-inflammatory ingredients–they both are spectacular wound healers. So I suspect those ingredients could be the cause for the in-vitro improvement, not necessarily the results of a juiced up bioelectric impulse.
I need to crack the books for this one, but my initial response is that Cytomimic Technology is a short circuit.
{ 1 trackback }